J&J to ship children’s medicine amid House committee hearing
WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children’s medicines following a nationwide recall.
J&J CEO William Weldon said nearly 1 million bottles of the medicine — which he did not disclose — will be available for release next week. The drug maker met with the House Committee on Oversight and Government Reform on Thursday to examine the circumstances surrounding J&J’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.
On Sept. 16, J&J’s consumer group chair Colleen Goggins said she would retire from her post on March 1, 2011.
Pharmacy groups launch e-health task force
WASHINGTON Staking a firm claim to the emerging technology revolution in health care, nine national pharmacy organizations Wednesday unveiled a new, joint task force to grapple with the challenges and opportunities posed by information technology.
The so-called Pharmacy e-Health Information Technology Collaborative will focus on the pharmacy profession’s technology needs “to ensure that they are addressed and integrated into the framework of the U.S. health information technology infrastructure,” the groups noted in a joint statement. “In doing so, the collaborative is committed to creating a comprehensive and unified approach, ensuring optimal integration of pharmacy’s requirements and contributions into the electronic health record.”
Among the collaborative’s founding members: the American Pharmacists Association, the National Community Pharmacists Association, Academy of Managed Care Pharmacy, Accreditation Council for Pharmacy Education, American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, American Society of Consultant Pharmacists, American Society of Health-System Pharmacists and National Alliance of State Pharmacy Associations.
“In order for patients to receive optimal care, pharmacists need to have the ability to access and contribute to relevant, patient-specific information from the EHR. The work of the collaborative will focus on achieving this goal,” said Tom Menighan, EVP and CEO of APhA, who will chair the working group.
Serving as its director will be Rachelle “Shelly” Spiro, a pharmacist and long-term care specialist who heads Spiro Consulting. Spiro is active in national pharmacy associations, standards development organizations and is a leader in pharmacy health IT.
Lansinoh names new VP marketing
ALEXANDRIA, Va. A maker of breast-feeding products has named Michael Barclay, a former SC Johnson brand manager, as its new VP marketing.
In his new role at Lansinoh, Barclay will coordinate all North American marketing activities while leading the brand marketing, consumer relations and professional relations teams. He will report to Lansinoh North America president Diane Manwaring. Prior to joining Lansinoh, Barclay was the brand manager for SC Johnson’s wax division and category manager for Frito-Lay’s U.K. division.
“Lansinoh has made great strides in the last several years and continues to work toward aggressive goals for growth in 2011 and beyond,” said Kevin Vyse-Peacock, CEO of Lansinoh. “Michael brings to the team extensive experience in product management and consumer packaged goods. He has the strategic thinking skills needed to direct the development of creative, effective, socially integrated marketing campaigns. We’re excited to have him on board.”